BioSpace News Archive

Business

AIT Therapeutics Reports Third Quarter 2017 Financial Results

The Company had cash and cash equivalents of $3.8 million at September 30, 2017, compared to $5.2 million at June 30, 2017.

November 3, 2017
·
15 min read
Business

Gregory B. Brown M.D. Appointed to the Board of Directors of Cambrex Corporation

Dr. Brown’s appointment increases the size of the Board to ten members.

November 3, 2017
·
1 min read
Business

Symic Bio Appoints Wayne Froland, Ph.D., as Executive VP of Technical Operations

Dr. Froland has over 20 years of experience in industry primarily focusing on process development in biopharma manufacturing.

November 3, 2017
·
2 min read
Business

Mission Bio Adds to Executive Team to Move Precision Medicine Forward

Joining the company are Pat Brooks as Senior Vice President of Sales and Sales Operations; Rebecca Galler as Senior Vice President of Marketing; and Keith Jones, Ph.D., as Senior Vice President of Product Development.

November 3, 2017
·
4 min read
Genetown

Alnylam Reports Positive Preliminary Results From Ongoing Phase I/II Study of Lumasiran (ALN-GO1) in Patients With Primary Hyperoxaluria Type 1 (PH1)

Results were presented today at the American Society of Nephrology (ASN) Kidney Week 2017 Annual Meeting, being held October 31 to November 5, 2017 in New Orleans, Louisiana.

November 3, 2017
·
13 min read
Business

Accelerate Diagnostics Reports Q3 2017 Financial Results

The company further reported signed agreements for 295 instruments year to date.

November 3, 2017
·
9 min read
Business

Radius Health Reports Third Quarter 2017 Financial and Operating Results and Provides Business Update

Third quarter reported sales of TYMLOS in the U.S. (the first full quarter since its launch) were approximately $3.5 million.

November 3, 2017
·
20 min read
Business

BASF to Enter Medical Foods Market in the U.S. With DIEM Labs

As part of this agreement, BASF will use its scientific expertise and state-of-the-art manufacturing capabilities to provide a first-to-the-market medical food product to patients with NAFLD.

November 3, 2017
·
4 min read
Business

Titan Pharma Schedules Conference Call to Review Third Quarter 2017 Financial Results

The call will be hosted by Sunil Bhonsle, president and CEO; Kate Beebe, Ph.D., executive vice president and chief development officer; Brian Crowley, vice president of finance; and Marc Rubin, M.D., executive chairman.

November 3, 2017
·
3 min read
Policy

VIVUS Completes Tacrolimus Pre-IND Meeting With FDA

VIVUS is on track to file this IND in the first half of 2018.

November 3, 2017
·
2 min read